Details
Eleven activities covering various endocrine topics; the most recent are:
• Above and Beyond Glycemic Control
• Above and Beyond Glycemic Control: Reducing the Risk of Cardiovascular Disease
Before the Breaking Point: Reducing the Risk of Osteoporotic Fracture
• Practical Lipidology: Best of Lipid Forum
• Managing the Full Spectrum of Cardiovascular Risk Factors: A Closer Look at GLP-1 Agonists
• The New Treatment Paradigm in Obesity: Proper Patient Selection, Assessment of Comorbidities, and Stepped Interventions
• Dialogues in Diabetes: Volume 2, Number 1
• Growth Hormone Deficiency and Other Causes of Short Stature: Trends in Diagnosis, Evaluation, and Treatment in Children and Adults
• GLP-1 Agonists: Examining New Data on Cardiovascular Risk Reduction, Combination Insulin Therapy, and Adherence
• Weighing in on the Beneficial Effects of GLP-1 Agonists: Assessing Cardiovascular Risk Reduction, Combination Therapy and Adherence
• Cardiovascular Risk Reduction
Target Audience: Physicians specializing in Endocrinology